Risk of Malignancy Index (RMI) — Adnexal Mass
ورودیهای بالینی بیمار
حداقل ۰ — حداکثر ۳
حداقل ۰ — حداکثر ۱۰۰۰۰ • واحد: U/mL
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Low risk0–200
- High risk≥ 200.1
The Risk of Malignancy Index (RMI) — Adnexal Mass calculates calculating gestational age, evaluating maternal-fetal wellbeing, and assessing perinatal complications. Key inputs include u score. Scores guide determining delivery timing, administering antenatal corticosteroids or tocolytics, and obstetric monitoring. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Risk of Malignancy Index (Jacobs 1990) for adnexal masses: RMI = ultrasound score × menopausal score × CA-125 (U/mL). U: 0 (no features), 1 (1 feature), 3 (≥2 features) — features: multilocular cyst, solid areas, bilaterality, ascites, metastases. M: 1 premenopausal, 3 postmenopausal. RMI >200 = high risk of malignancy.
Clinical Indication
The Risk of Malignancy Index (RMI) — Adnexal Mass is indicated for bedside clinical practice to support Risk of Malignancy Index (Jacobs 1990) for adnexal masses: RMI = ultrasound score × menopausal score × CA-125 (U/mL). U: 0 (no features), 1 (1 feature), 3 (≥2 features) — features: multilocular cyst, solid areas, bilaterality, ascites, metastases. M: 1 premenopausal, 3 postmenopausal. RMI >200 = high risk of malignancy.. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Pregnant individuals across antepartum, intrapartum, and postpartum stages, or patients with acute gynecologic conditions. Clinical application is indicated across Labor and delivery suites, obstetric triage, antenatal clinics, and gynecologic surgical units.
Limitations & Contraindications
Normal gestational physiological adaptations alter baseline plasma volume, serum creatinine, and resting heart rate.
Clinical Pearls & Action Plan
Simultaneous surveillance of maternal hemodynamic stability and continuous electronic fetal heart rate monitoring is paramount.
RMI = U × M × CA-125.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| u_score | integer | Yes | Ultrasound score U (0, 1, or 3) |
| menopausal | string | Yes | Menopausal status |
| ca125 | float | Yes | CA-125 level(U/mL) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| 0–200 | Low risk | Low risk |
| ≥ 200.1 | High risk | High risk |
Evidence-Based References (EBM)
- Jacobs I, Oram D, Fairbanks J, et al. A risk of malignancy index incorporating CA 125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer. Br J Obstet Gynaecol. 1990;97(10):922-929.